References
- Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50 , 1088-101. https://doi.org/10.2307/2533446
- Bidard FC, Huguet F, Louvet C, et al (2013). Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol, 24, 2057-61. https://doi.org/10.1093/annonc/mdt176
- Cen P, Ni X, Yang J, et al (2012). Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochim Biophys Acta, 1826, 350-6.
- Cohen SJ, Punt CJ, Iannotti N, et al (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol, 26, 3213-21. https://doi.org/10.1200/JCO.2007.15.8923
- Cristofanilli M, Budd GT, Ellis MJ, et al (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med, 351, 781-91. https://doi.org/10.1056/NEJMoa040766
- de Albuquerque A, Kubisch I, Breier G, et al (2012). Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study, Oncology, 82, 3-10. https://doi.org/10.1159/000335479
- Dong X, Alpaugh KR, Cristofanilli M (2012). Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis. Chin J Cancer Res, 24, 388-98. https://doi.org/10.1007/s11670-012-0279-4
- Ghaneh P, Costello E, Neoptolemos JP (2008). Biology and management of pancreatic cancer. Postgrad Med J, 84, 478-97. https://doi.org/10.1136/gut.2006.103333
- Goodman OB, Jr Symanowski JT, Loudyi A, et al (2011). Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer. Clin Genitourin Cancer, 9, 31-8. https://doi.org/10.1016/j.clgc.2011.04.001
- Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. https://doi.org/10.1136/bmj.327.7414.557
- Hiltermann TJ, Pore MM, van den Berg, et al (2012). Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol, 23, 2937-42. https://doi.org/10.1093/annonc/mds138
- Hofman V, Ilie MI, Long E, et al (2011). Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. Int J Cancer, 129, 1651-60. https://doi.org/10.1002/ijc.25819
- Khoja L, Backen A, Sloane R, et al (2012). A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer, 106, 508-16. https://doi.org/10.1038/bjc.2011.545
- Kokhanenko, NIu, Ignashov AM, et al (2001). Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer. Vopr Onkol, 47, 294-7.
- Kowalewska M, Chechlinska M, Markowicz S, et al (2006). The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes. Eur J Cancer, 42, 2671-4. https://doi.org/10.1016/j.ejca.2006.05.036
- Kurihara T, Itoi T, Sofuni A, et al (2008). Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepatobiliary Pancreat Surg, 15, 189-95. https://doi.org/10.1007/s00534-007-1250-5
- Ma XL, Xiao ZL, Liu L, et al (2012). Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. Asian Pac J Cancer Prev, 13, 1137-44. https://doi.org/10.7314/APJCP.2012.13.4.1137
- Mataki Y, Takao S, Maemura K, et al (2004). Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during followup period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses. Clin Cancer Res, 10, 3807-14. https://doi.org/10.1158/1078-0432.CCR-03-0130
- Muller P, Schlimok G (2000). Bone marrow “micrometastases” of epithelial tumors: detection and clinical relevance. J Cancer Res Clin Oncol, 126, 607-18. https://doi.org/10.1007/PL00008472
- Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34. https://doi.org/10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
- Sergeant G, Roskams T, van Pelt J, et al (2011). Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. BMC Cancer, 11, 47. https://doi.org/10.1186/1471-2407-11-47
- Sergeant G, van Eijsden R, Roskams T, et al (2012). Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery. BMC Cancer, 12, 527. https://doi.org/10.1186/1471-2407-12-527
- Soeth E, Grigoleit U, Moellmann B, et al (2005). Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol, 131, 669-76. https://doi.org/10.1007/s00432-005-0008-1
- Tarhan MO, Gonel A, Kucukzeybek Y, et al (2013). Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results. Asian Pac J Cancer Prev, 14, 1725-9. https://doi.org/10.7314/APJCP.2013.14.3.1725
- Tierney JF, Stewart LA, Ghersi D, et al (2007). Practical methods for incorporating summary time-to-event data into metaanalysis. Trials, 8, 16. https://doi.org/10.1186/1745-6215-8-16
- Tjensvoll K, Nordgard O, Smaaland R (2013). Circulating tumor cells in pancreatic cancer patients: Methods of detection and clinical implications, Int J Cancer, 8, 16.
- Uchikura K, Takao S, Nakajo A, et al (2002). Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. Ann Surg Oncol, 9, 364-70. https://doi.org/10.1007/BF02573871
- Uen YH, Lu CY, Tsai HL, et al (2008). Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol, 15, 2120-8. https://doi.org/10.1245/s10434-008-9961-7
- Wang FB, Yang XQ, Yang S, et al (2011). A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients--a meta-analysis. Asian Pac J Cancer Prev, 12, 2629-35.
- Williamson PR, Smith CT, Hutton JL, et al (2002). Aggregate data meta-analysis with time-to-event outcomes, Stat Med, 21, 3337-51. https://doi.org/10.1002/sim.1303
- Zhou J, Hu L, Yu Z, et al (2011). Marker expression in circulating cancer cells of pancreatic cancer patients. J Surg Res, 171, 631-6. https://doi.org/10.1016/j.jss.2010.05.007
- Zippelius A, Pantel K (2000). RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann N Y Acad Sci, 906, 110-23.
Cited by
- Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps vol.15, pp.10, 2015, https://doi.org/10.1039/C5LC00226E
- Liquid biopsy vol.27, pp.6, 2015, https://doi.org/10.1097/CCO.0000000000000223
- Clinicopathological and Prognostic Significance of Circulating Tumor Cells in Patients with Head and Neck Cancer: A Meta-Analysis vol.05, pp.02, 2016, https://doi.org/10.4236/ijmpcero.2016.52015
- Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes? vol.41, pp.2, 2017, https://doi.org/10.1159/000458736
- Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial pp.1573-0646, 2018, https://doi.org/10.1007/s10637-018-0639-0